These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

487 related articles for article (PubMed ID: 34024839)

  • 1. Altered Gut Microbiota in Adults with Subjective Cognitive Decline: The SILCODE Study.
    Sheng C; Lin L; Lin H; Wang X; Han Y; Liu SL
    J Alzheimers Dis; 2021; 82(2):513-526. PubMed ID: 34024839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of gut microbiota and plasma amyloid-β as a potential index for identifying preclinical Alzheimer's disease: a cross-sectional analysis from the SILCODE study.
    Sheng C; Yang K; He B; Du W; Cai Y; Han Y
    Alzheimers Res Ther; 2022 Feb; 14(1):35. PubMed ID: 35164860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered microbiomes distinguish Alzheimer's disease from amnestic mild cognitive impairment and health in a Chinese cohort.
    Liu P; Wu L; Peng G; Han Y; Tang R; Ge J; Zhang L; Jia L; Yue S; Zhou K; Li L; Luo B; Wang B
    Brain Behav Immun; 2019 Aug; 80():633-643. PubMed ID: 31063846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mild cognitive impairment has similar alterations as Alzheimer's disease in gut microbiota.
    Li B; He Y; Ma J; Huang P; Du J; Cao L; Wang Y; Xiao Q; Tang H; Chen S
    Alzheimers Dement; 2019 Oct; 15(10):1357-1366. PubMed ID: 31434623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of the composition and functions of the oral and gut microbiotas in Alzheimer's patients.
    Chen L; Xu X; Wu X; Cao H; Li X; Hou Z; Wang B; Liu J; Ji X; Zhang P; Li H
    Front Cell Infect Microbiol; 2022; 12():942460. PubMed ID: 36093178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered Gut Microbiota and Its Clinical Relevance in Mild Cognitive Impairment and Alzheimer's Disease: Shanghai Aging Study and Shanghai Memory Study.
    Zhu Z; Ma X; Wu J; Xiao Z; Wu W; Ding S; Zheng L; Liang X; Luo J; Ding D; Zhao Q
    Nutrients; 2022 Sep; 14(19):. PubMed ID: 36235612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive Function Associated with Gut Microbial Abundance in Sucrose and S-Adenosyl-L-Methionine (SAMe) Metabolic Pathways.
    Jeong S; Huang LK; Tsai MJ; Liao YT; Lin YS; Hu CJ; Hsu YH
    J Alzheimers Dis; 2022; 87(3):1115-1130. PubMed ID: 35431236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disruptions of Gut Microbiota are Associated with Cognitive Deficit of Preclinical Alzheimer's Disease: A Cross-Sectional Study.
    Yu B; Wan G; Cheng S; Wen P; Yang X; Li J; Tian H; Gao Y; Zhong Q; Liu J; Li J; Zhu Y
    Curr Alzheimer Res; 2024; 20(12):875-889. PubMed ID: 38529601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut Microbiome Features of Chinese Patients Newly Diagnosed with Alzheimer's Disease or Mild Cognitive Impairment.
    Guo M; Peng J; Huang X; Xiao L; Huang F; Zuo Z
    J Alzheimers Dis; 2021; 80(1):299-310. PubMed ID: 33523001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and first baseline data of the DZNE multicenter observational study on predementia Alzheimer's disease (DELCODE).
    Jessen F; Spottke A; Boecker H; Brosseron F; Buerger K; Catak C; Fliessbach K; Franke C; Fuentes M; Heneka MT; Janowitz D; Kilimann I; Laske C; Menne F; Nestor P; Peters O; Priller J; Pross V; Ramirez A; Schneider A; Speck O; Spruth EJ; Teipel S; Vukovich R; Westerteicher C; Wiltfang J; Wolfsgruber S; Wagner M; Düzel E
    Alzheimers Res Ther; 2018 Feb; 10(1):15. PubMed ID: 29415768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut Microbiota Composition Is Related to AD Pathology.
    Verhaar BJH; Hendriksen HMA; de Leeuw FA; Doorduijn AS; van Leeuwenstijn M; Teunissen CE; Barkhof F; Scheltens P; Kraaij R; van Duijn CM; Nieuwdorp M; Muller M; van der Flier WM
    Front Immunol; 2021; 12():794519. PubMed ID: 35173707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut Microbiota Changes and Their Correlation with Cognitive and Neuropsychiatric Symptoms in Alzheimer's Disease.
    Zhou Y; Wang Y; Quan M; Zhao H; Jia J
    J Alzheimers Dis; 2021; 81(2):583-595. PubMed ID: 33814442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative Microbiomes and Intestinal Barrier Function Can Differentiate Prodromal Alzheimer's Disease From Normal Neurocognition in Elderly Patients Scheduled to Undergo Orthopedic Surgery.
    Duan M; Liu F; Fu H; Lu S; Wang T
    Front Cell Infect Microbiol; 2021; 11():592842. PubMed ID: 33869072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations of gut microbiota are associated with brain structural changes in the spectrum of Alzheimer's disease: the SILCODE study in Hainan cohort.
    He B; Sheng C; Yu X; Zhang L; Chen F; Han Y
    Front Aging Neurosci; 2023; 15():1216509. PubMed ID: 37520126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut Microbiota is Altered in Patients with Alzheimer's Disease.
    Zhuang ZQ; Shen LL; Li WW; Fu X; Zeng F; Gui L; Lü Y; Cai M; Zhu C; Tan YL; Zheng P; Li HY; Zhu J; Zhou HD; Bu XL; Wang YJ
    J Alzheimers Dis; 2018; 63(4):1337-1346. PubMed ID: 29758946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-sectional and longitudinal characterization of SCD patients recruited from the community versus from a memory clinic: subjective cognitive decline, psychoaffective factors, cognitive performances, and atrophy progression over time.
    Kuhn E; Moulinet I; Perrotin A; La Joie R; Landeau B; Tomadesso C; Bejanin A; Sherif S; De La Sayette V; Desgranges B; Vivien D; Poisnel G; Chételat G
    Alzheimers Res Ther; 2019 Jul; 11(1):61. PubMed ID: 31286994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disturbed microbial ecology in Alzheimer's disease: evidence from the gut microbiota and fecal metabolome.
    Xi J; Ding D; Zhu H; Wang R; Su F; Wu W; Xiao Z; Liang X; Zhao Q; Hong Z; Fu H; Xiao Q
    BMC Microbiol; 2021 Aug; 21(1):226. PubMed ID: 34384375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subjective Cognitive Decline in Preclinical Alzheimer's Disease.
    Rabin LA; Smart CM; Amariglio RE
    Annu Rev Clin Psychol; 2017 May; 13():369-396. PubMed ID: 28482688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneity of Amyloid Binding in Cognitively Impaired Patients Consecutively Recruited from a Memory Clinic: Evaluating the Utility of Quantitative 18F-Flutemetamol PET-CT in Discrimination of Mild Cognitive Impairment from Alzheimer's Disease and Other Dementias.
    Bao YW; Chau ACM; Chiu PK; Shea YF; Kwan JSK; Chan FHW; Mak HK
    J Alzheimers Dis; 2021; 79(2):819-832. PubMed ID: 33361593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study of gut microbiota alterations in Alzheimer's dementia patients from Kazakhstan.
    Kaiyrlykyzy A; Kozhakhmetov S; Babenko D; Zholdasbekova G; Alzhanova D; Olzhayev F; Baibulatova A; Kushugulova AR; Askarova S
    Sci Rep; 2022 Sep; 12(1):15115. PubMed ID: 36068280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.